life scienc tool diagnost increas target price
take step forward condit eu approv eu commiss
condit approv dhr acquisit gener electr biopharma unit subject
divestitur dhr label-fre biomolecular character chromatographi hardwar
resin microcarri particl valid standard busi single-us tangenti
flow filtrat system includ life scienc segment remind
remedi packag alreadi larg broadcast reach
divestitur agreement sartoriu ag late octob see ge deal progress
repres million revenu note previous consid
expect divest single-us tangenti filtrat system repres estimate
million revenu like de minimi ep impact remain posit bias
pend acquisit still expect close dhr focu
enhanc exposur life scienc arena sinc spin-off
clearli pay demonstr acceler organ growth trajectori
updat model complet dental spin fine-tun pro forma
model exclud dental segment onward
follow spin-off dhr dentalco brace growth
initi neutral complet exchang offer week oper
assumpt remain busi remain unchang ep move
aforement dynam conjunct refin
estim anticip deal close end vs
reiter outperform share ytd vs
confid near long term growth prospect increas exposur faster-
grow end-market particularli aforement pend acquisit
biopharma busi spin-off envista hold former dentalco moreov
continu expand exposur recur revenu stream revenu
opportun healthi innov pipelin runway margin improv
capit deploy rais tp enhanc
convict lt prospect risk includ util macro condit miscu
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
lead manufactur system instrument
consum broad array purpos custom primari
dental environment health/appli scienc
blue sky scenario assum signific acceler
key end market global signific rebound dental trend better
expect implement db acquir compani market
share gain materi margin expans
grey sky scenario base signific weak
key end market prolong weak dental demand trend
deceler core growth acquisit integr headwind
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
